PATENT CLAIM ANALYSIS

Application Number: 16130820
Application Type: Utility
Filing Date: 2018-09
Publication Date: 2019-01
Patent Classification: ["514", "021800"]

Abstract:
New polypeptide agonists of AT2R are disclosed, as well as pharmaceutical compositions comprising the agonists, methods of their use in the treatment of diseases, conditions or disorders characterized by insufficient AT2R activity or excessive AT1R activity, and methods of their use as laboratory reagents for research purposes.

Claim (Index 1):
A method of activating an AT2R protein or inhibiting an AT1R protein in a cell expressing the AT2R protein comprising:\n providing to the cell an effective amount of an AT2R agonist comprising an amino acid sequence that corresponds to the formula:\n A1-A2-A3 -A4-A5 -A6 \n wherein: A1 is Lys A2 is Pro, 3Hyp or 4Hyp A3 is Leu or Ile A4 is Lys A5 is Pro, 3Hyp or 4Hyp, and A6 is Trp.

Metadata:
- Claim Count in Document: 5.0
- Percentile: 97.0
- Lexical Diversity: 1.44444
- Patent Class: 514.0
- Transitional Phrase Type: open
- Component Type: 1
- Foreign Priority: False
- Related Applications: ['15595517', '15648184', '14773041', '13896937', '12046038']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.7031907581955616
- 35 USC 102 Novelty (BERT): 0.6077797681447081
- Combined Prediction Score: 0.6936496591904764
- Mean Citation Score: 298.427244
- Max Citation Score: 609.76044
- Similarity Product: 436.02670976479055

Labels:
- Claim Label 101: 1
- Claim Label 102: 1
- Claim Label 103: 1
- Claim Label 112: 1
- Combined Label: 1
- Label 101 Adjusted: 1

Dataset: test